VAERS reports by lot

GSK Varicella/Shingles lot 9XC39: VAERS reports

105 VAERS reports list lot 9XC39 as a GSK Varicella/Shingles vaccine, received between 2017-12-12 and 2022-12-15. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
105
Reports
8%
Marked serious
0
With a death outcome
14
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction11329%
General / Systemic (non-local)8622%
Musculoskeletal4010%
Dermatological (non-injection-site)3810%
Neurological359%
Allergic / Anaphylactic308%
Cardiac / Cardiovascular267%
Gastrointestinal195%
Respiratory41%
Thrombotic / Hematological21%
Psychiatric / Neuropsychiatric21%
Autoimmune / Immune-mediated10%

Where reports came from

U.S. state of the reporter, where given (top 12).

California12
Virginia8
Texas8
Illinois6
Colorado6
West Virginia5
Arizona5
Washington4
Michigan4
North Carolina4
Indiana4
Wisconsin4

Reports by month received

2017-124
2018-0112
2018-0224
2018-0322
2018-0416
2018-059
2018-067
2018-074
2018-081
2018-091
2018-102
2018-121
2019-031
2022-121

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.